Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-28596

Single-particle
3.5 Å
EMD-28596 Deposition: 17/10/2022
Map released: 02/11/2022
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-28596

CryoEM Structure of NLRP3 NACHT domain in complex with G2394

EMD-28596

Single-particle
3.5 Å
EMD-28596 Deposition: 17/10/2022
Map released: 02/11/2022
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: NLRP3 NACHT domain
Fitted models: 8etr

Deposition Authors: Murray JM, Johnson MC
Overcoming Preclinical Safety Obstacles to Discover ( S )- N -((1,2,3,5,6,7-Hexahydro- s -indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5 H -pyrazolo[5,1- b ][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 Inhibitor.
PUBMED: 36279149
DOI: doi:10.1021/acs.jmedchem.2c01250
ISSN: 0022-2623
ASTM: JMCMAR
Grant Support: